Fosun Pharma Conducted Human Safety Trials for Pfizer's mRNA Vaccines in China. Guess How China Responded to the Data?

After completing Pfizer's initial mRNA human safety trials, China banned Pfizer's mRNA technology for use in Chinese citizens. The FDA authorized Pfizer's mRNA as safe for U.S. citizens.

May 13, 2023

∙ Paid

May 12, 2023: According to the NIH clinical trial database, Chinese biotech $44 billion dollar giant, Fosun Pharma, conducted the initial Pfizer/BioNTech Phase-1 human safety trials in 144 civilians in China. After Fosun Pharma completed their clinical evaluation of the safety of Pfizer’s mRNA vaccines for human use, China banned Pfizer's mRNA lipid nanoparticle technology for use in Chinese citizens.

Fosun Pharma Conducted Human Safety Trials for Pfizer's mRNA Vaccines in China. Guess How China Responded to the Data?

After completing Pfizer's initial mRNA human safety trials, China banned Pfizer's mRNA technology for use in Chinese citizens. The FDA authorized Pfizer's mRNA as safe for U.S. citizens.

That’s worth repeating.

This post is for paid subscribers